UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medical supplies trade with China turn to black in 2017
by Nam Doo-hyun
2017-12-04 16:09
Cord blood biotech firms enjoy stock price gains this year
by Nam Doo-hyun
2017-12-04 15:02
Tego Science shares surge on robust earnings
by Nam Doo-hyun
2017-12-01 11:48
Sexual scandal at Pfizer Korea belatedly uncovered
by Nam Doo-hyun
2017-11-30 16:29
Nanomedicine market to grow rapidly: report
by Nam Doo-hyun
2017-11-29 16:47
라인
‘Weak digital healthcare sector might be eaten by foreign capital’
by Nam Doo-hyun
2017-11-29 14:39
Hospital wins patent in VR treatment for cognitive disorders
by Nam Doo-hyun
2017-11-27 16:05
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
by Nam Doo-hyun
2017-11-27 13:13
Clinical trials on CAR-T cell therapies surge in two years
by Nam Doo-hyun
2017-11-24 15:53
Zuellig Pharma Korea CEO treats workers like ‘dogs and pigs’: union
by Nam Doo-hyun
2017-11-21 13:43
라인
‘Pharmaceuticals’ main mission is R&D, not marketing’
by Nam Doo-hyun
2017-11-20 16:37
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022
by Nam Doo-hyun
2017-11-17 13:53
Earthquake hits biopharmaceutical factories in Pohang
by Nam Doo-hyun
2017-11-16 15:55
New US guideline adds 6.5 million to Korean hypertension patients
by Nam Doo-hyun
2017-11-16 14:38
InBody stocks rise on record Q3 earnings
by Nam Doo-hyun
2017-11-14 15:49
라인
Do adverse effects of statin increase if more people know about them?
by Nam Doo-hyun
2017-11-14 06:30
Biopharmaceutical firms rank high in Kosdaq market cap
by Nam Doo-hyun
2017-11-13 15:25
Big-3 companies take up half of healthcare market cap
by Nam Doo-hyun
2017-11-09 11:21
Daewoong salespersons unhappy about management system
by Nam Doo-hyun
2017-11-08 16:48
ViroMed, Reyon in legal battle over gene therapy patent rights
by Nam Doo-hyun
2017-11-07 14:10
-
이전
11
12
13
14
15
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top